Pharma News

Today, the U.

Danish drugmaker Novo Nordisk made waves last year with the approval of its oral diabetes med Rybelsus.

Like many of its peers, Regeneron responded swiftly to the COVID-19 pandemic and moved treatment candidates quickly through testing.

TOKYO (Reuters) - Japan’s Takeda Pharmaceutical Co is looking at making vaccines a core business after completing asset sales to lower debt following its takeover of Shire Plc, Chief Executi...

Pfizer and partner BioNTech said Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relie...

AstraZeneca missed a September deadline for its COVID-19 vaccine in the U.

Though it's still integrating its Celgene buy, Bristol Myers Squibb already looks quite different than it did this time last year.

Oregon became the first state to decriminalize hard drugs like heroin, cocaine and meth in a 59-41% vote as of early Wednesday morning, according to the Associated Press.

(Reuters) - Biogen Inc has shown “exceptionally persuasive” evidence that its experimental Alzheimer’s disease drug is effective, U.

SUZHOU, China (Reuters) - BioNTech’s Chinese partner Shanghai Fosun Pharmaceutical Group does not plan to run further clinical trials of the German firm’s coronavirus vaccine candidate tha...

Royalty Pharma’s $3.

Bristol Myers Squibb’s tyrosine kinase 2 (TYK2) inhibitor deucravacitinib outperformed Amgen’s Otezla in a phase III psoriasis study, the pharma company revealed yesterday.